NO20070509L - Karboranylporfyriner og anvendelser derav - Google Patents

Karboranylporfyriner og anvendelser derav

Info

Publication number
NO20070509L
NO20070509L NO20070509A NO20070509A NO20070509L NO 20070509 L NO20070509 L NO 20070509L NO 20070509 A NO20070509 A NO 20070509A NO 20070509 A NO20070509 A NO 20070509A NO 20070509 L NO20070509 L NO 20070509L
Authority
NO
Norway
Prior art keywords
methods
compounds
tetrafenylporphyrin
tumors
carborane
Prior art date
Application number
NO20070509A
Other languages
English (en)
Norwegian (no)
Inventor
Haitao Wu
Michiko Miura
Original Assignee
Brookhaven Science Ass Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brookhaven Science Ass Llc filed Critical Brookhaven Science Ass Llc
Publication of NO20070509L publication Critical patent/NO20070509L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/009Neutron capture therapy, e.g. using uranium or non-boron material
    • A61K41/0095Boron neutron capture therapy, i.e. BNCT, e.g. using boronated porphyrins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10Organic compounds
    • A61K49/101Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
    • A61K49/106Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being cyclic, e.g. DOTA
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/0474Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0485Porphyrins, texaphyrins wherein the nitrogen atoms forming the central ring system complex the radioactive metal
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F1/00Compounds containing elements of Groups 1 or 11 of the Periodic Table
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F1/00Compounds containing elements of Groups 1 or 11 of the Periodic Table
    • C07F1/08Copper compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F3/00Compounds containing elements of Groups 2 or 12 of the Periodic Table

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Molecular Biology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Biochemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Radiation-Therapy Devices (AREA)
NO20070509A 2004-06-28 2007-01-26 Karboranylporfyriner og anvendelser derav NO20070509L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/878,138 US6989443B2 (en) 2004-06-28 2004-06-28 Carboranylporphyrins and uses thereof
PCT/US2005/022061 WO2006012140A1 (en) 2004-06-28 2005-06-22 Carboranylporphyrins and uses thereof

Publications (1)

Publication Number Publication Date
NO20070509L true NO20070509L (no) 2007-01-29

Family

ID=35505984

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20070509A NO20070509L (no) 2004-06-28 2007-01-26 Karboranylporfyriner og anvendelser derav

Country Status (11)

Country Link
US (1) US6989443B2 (enExample)
EP (1) EP1778082A4 (enExample)
JP (1) JP2008504365A (enExample)
KR (1) KR20070033006A (enExample)
CN (1) CN1988848B (enExample)
AU (1) AU2005267390B2 (enExample)
CA (1) CA2572287A1 (enExample)
IL (1) IL180365A (enExample)
NO (1) NO20070509L (enExample)
NZ (1) NZ552877A (enExample)
WO (1) WO2006012140A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070093463A1 (en) * 2004-05-20 2007-04-26 Brookhaven Science Associates, Llc Radiation enhancement agent for X-ray radiation therapy and boron neutron-capture therapy
US8287839B2 (en) * 2006-12-04 2012-10-16 Brookhaven Science Associates, Llc Carboranylporphyrins and uses thereof
US8444953B2 (en) * 2007-03-22 2013-05-21 Brookhaven Science Associates, Llc Symmetric and asymmetric halogen-containing metallocarboranylporphyrins and uses thereof
US20080279781A1 (en) * 2007-05-10 2008-11-13 Brookhaven Science Associates, Llc Glycosylated Carboranylporphyrins and Uses Thereof
JP5745415B2 (ja) * 2009-09-17 2015-07-08 国立大学法人九州大学 ポルフィリン化合物
CN102260269B (zh) * 2010-05-25 2013-11-06 苏州和健医药科技有限公司 一种含有卟啉或二氢卟吩的树状化合物及其应用
GB201212409D0 (en) 2012-07-12 2012-08-22 Morex Dev Partners Llp Cancer treatment
JP6699004B2 (ja) * 2015-08-25 2020-05-27 住友重機械工業株式会社 中性子捕捉療法システム及び中性子捕捉療法システムの制御方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4783529A (en) 1985-12-03 1988-11-08 Research Corporation Technologies Rapid synthesis of radiolabeled porphyrin complexes for medical application
US5162231A (en) 1989-10-25 1992-11-10 Cole Dean A Method of using 5,10,15,20-tetrakis(carboxyphenyl)porphine for detecting cancers of the lung
US4959356A (en) 1989-05-26 1990-09-25 The United States Of America As Represented By The United States Department Of Energy Porphyrins for boron neutron capture therapy
FR2656866B1 (fr) 1990-01-10 1992-05-15 Cis Bio Int Derives de porphyrine et metalloporphyrines eventuellement couples a une molecule biologiquement active, et composition pharmaceutique les contenant.
US5149801A (en) 1990-11-21 1992-09-22 The Regents Of The University Of California Boronated porphyrin compounds
US5654423A (en) 1990-11-21 1997-08-05 Regents Of The University Of California Boronated metalloporphyrine and therapeutic methods
US5312896A (en) 1992-10-09 1994-05-17 Sri International Metal ion porphyrin-containing poly(imide)
DE4305523A1 (de) 1993-02-17 1994-08-18 Diagnostikforschung Inst Meso-Tetraphenylporphyrin-Komplexverbindungen, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Mittel
IT232801Y1 (it) * 1994-03-07 2000-01-19 Imbac Spa Fianco di cassonetto con gambo laterale di innesto asportabile e intercambiabile
US5563132A (en) 1994-06-21 1996-10-08 Bodaness; Richard S. Two-step cancer treatment method
US5877165A (en) 1995-11-02 1999-03-02 Brookhaven Science Associates Boronated porhyrins and methods for their use
US5955586A (en) 1996-03-22 1999-09-21 Sessler; Jonathan L. Highly boronated derivatives of texaphyrins
WO1998030102A1 (en) 1997-01-09 1998-07-16 Emory University Non-iron metalloporphyrins and methods of use
US6010805A (en) 1998-05-26 2000-01-04 United States Of America As Represented By The Secretary Of The Air Force Ion conducting electrolyte material containing a lithium porphyrin complex
AU2001274827A1 (en) 2000-05-09 2001-11-20 The Regents Of The University Of California Porphyrin-based neutron capture agents for cancer therapy
DE60210074T2 (de) * 2001-06-06 2006-10-19 Brookhaven Science Associates Neue metalloporphyrine und ihre verwendung als radiosensibilisatoren für die strahlentherapie
US6566517B2 (en) 2001-06-06 2003-05-20 Brookhaven Science Associates, Llc Metalloporphyrins and their uses as imageable tumor-targeting agents for radiation therapy

Also Published As

Publication number Publication date
NZ552877A (en) 2010-03-26
AU2005267390B2 (en) 2011-01-20
IL180365A0 (en) 2007-06-03
CN1988848A (zh) 2007-06-27
EP1778082A1 (en) 2007-05-02
CA2572287A1 (en) 2006-02-02
US6989443B2 (en) 2006-01-24
CN1988848B (zh) 2010-12-15
US20050287073A1 (en) 2005-12-29
KR20070033006A (ko) 2007-03-23
AU2005267390A1 (en) 2006-02-02
WO2006012140A1 (en) 2006-02-02
HK1109039A1 (en) 2008-05-30
IL180365A (en) 2011-09-27
EP1778082A4 (en) 2010-09-22
JP2008504365A (ja) 2008-02-14

Similar Documents

Publication Publication Date Title
MX2009005904A (es) Carboranilporfirinas y usos de las mismas.
NO20070509L (no) Karboranylporfyriner og anvendelser derav
Gheewala et al. Photosensitizers in prostate cancer therapy
WO2006088476A3 (en) Carboranylporphyrins and uses thereof
WO2008122056A3 (en) Medical apparatus and method associated therewith
DE60210074D1 (de) Neue metalloporphyrine und ihre verwendung als radiosensibilisatoren für die strahlentherapie
DK1381611T3 (da) Metalsubstituerede ikke-centrosymmetriske phthalocyaninanaloger, fremstilling heraf og anvendelse i fotodynamisk terapi samt in vivo diagnostik
DE602004017290D1 (de) Konjugate für medizinische abbildungen umfassend träger, targeting-anteile und kontrastmittel
DK1698350T3 (da) Porphyrinbaserede forbindelser til billeddiagnostisk tumorundersögelse og fotodynamisk terapi
Bregadze et al. Conjugates of boron clusters with derivatives of natural chlorin and bacteriochlorin
Shliakhtsin et al. Pharmacokinetics and biodistribution of Photolon®(Fotolon®) in intact and tumor-bearing rats
ATE485836T1 (de) Mrt-geführte photodynamische therapie gegen krebs
Tanabe et al. Fluorescence detection of a new photosensitizer, PAD-S31, in tumour tissues and its use as a photodynamic treatment for skin tumours in dogs and a cat: a preliminary report
Spangler et al. Optimization of targeted two-photon PDT triads for the treatment of head and neck cancers
Kessel et al. Introduction to the Symposium-in-Print: Photodynamic Therapy
Eckhauser et al. Biodistribution of55Fe (II) phthalocyanine tetrasulphonate (55Fe (II)-TsPc)
Gao et al. Dual tumor control and neuroprotective efficacy of Boron Neutron Capture Therapy in orthotopic mouse glioma model
Wilson et al. Photodynamic therapy dosimetry: current status and the emerging challenge of immune stimulation
Li et al. The study of comparing the efficiency of ZnPc-PDT and HPD-PDT in killing mice lewis lung cancer cells
Grishacheva et al. Robot-assisted photodynamic therapy
Welsh Clinical, Technical, and Basic Science Progress in Helical Tomotherapy—The Pace Continues to Accelerate
Gomer et al. Los Angeles, CA 90027
Ismail et al. Applied photosensitizers classification for clinical photodynamic therapy
Hamblin et al. PHOTOMEDICINE
Rey et al. Photodynamic therapy (PDT): Theoretical study of porphycene and azaporphycene electronic transitions

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application